Korro Bio KRRO
NASDAQ KRRO
$13.18 +0.22 (+1.70%)
At close: Aug 21, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Change in Acquisitions & Divestments (2019 - 2026)

Korro Bio's (KRRO) quarterly Change in Acquisitions & Divestments came in at $13.0 million in Q1 2026, down 60.49% YoY from $32.9 million in Q1 2025, and down 13.33% on a QoQ basis from $15.0 million in Q4 2025.

Korro Bio (KRRO) Change in Acquisitions & Divestments (2019 - 2026) Analysis & Trends

Korro Bio (KRRO) has 8 years of Change in Acquisitions & Divestments data on file, last reported at $13.0 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 60.49% year-over-year to $13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.8 million (down 31.17% YoY) and the FY2025 annual result came in at $70.7 million, up 72.86% from the prior year.
  • Change in Acquisitions & Divestments declined to $13.0 million in Q1 2026, from $15.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $32.9 million in Q1 2025 to a low of $1000.0 in Q2 2025.
  • A 5-year average of $14.1 million and a median of $14.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
  • Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments sank 99.86% — and 2024, when it surged 1300.0%.
  • Tracing KRRO's Change in Acquisitions & Divestments over 5 years: stood at $16000.0 in 2022, then soared by 6150.0% to $1.0 million in 2023, then surged by 2590.0% to $26.9 million in 2024, then slumped by 44.24% to $15.0 million in 2025, then declined by 13.33% to $13.0 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $13.0 million (Q1 2026), $15.0 million (Q4 2025), and $22.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Korro Bio 231.77 Mn 116.73 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 12.00 Mn
Jun 30, 2026 12.00 Mn
Mar 31, 2026 13.00 Mn
Mar 31, 2026 13.00 Mn
Dec 31, 2025 15.00 Mn
Dec 31, 2025 15.00 Mn
Sep 30, 2025 22.80 Mn
Sep 30, 2025 22.80 Mn
Jun 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 32.90 Mn
Mar 31, 2025 32.90 Mn
Dec 31, 2024 26.90 Mn
Dec 31, 2024 26.90 Mn
Sep 30, 2024 14.00 Mn
Sep 30, 2024 14.00 Mn
Sep 30, 2023 1.00 Mn
Sep 30, 2023 1.00 Mn
Jun 30, 2023 1.00 Mn
Jun 30, 2023 1.00 Mn